Italia markets open in 2 hours 41 minutes

Bristol-Myers Squibb Company (BRM.F)

Frankfurt - Frankfurt Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
40,73-0,17 (-0,42%)
Alla chiusura: 04:51PM CEST
Schermo intero
Chiusura precedente40,90
Aperto40,79
Denaro0,00 x 50000
Lettera0,00 x 50000
Min-Max giorno40,57 - 41,04
Intervallo di 52 settimane40,57 - 63,50
Volume654
Media Volume961
Capitalizzazione83,108B
Beta (5 anni mensile)0,39
Rapporto PE (ttm)N/D
EPS (ttm)-2,88
Prossima data utili26 lug 2024
Rendimento e dividendo (futuro)2,25 (5,50%)
Data ex dividendo04 apr 2024
Stima target 1AN/D
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri